|
Indications and Dosage
Ophthalmic
Surface anaesthesia Adult: As 0.4% soln: For tonometry: Instill 1 drop into the conjunctival sac 1 min before measurement. For contact lens fitting: Additional drop 90 sec before fitting. For removal of foreign body or minor surgery: Instill 3 drops at 90 sec interval. For pterygium surgery: Instill 1 drop every min for 10 doses.
Child: Same as adult dose. |
|
Contraindications
Preterm neonate.
|
|
Special Precautions
Patient w/ eye infection. Prolonged use. Childn. Pregnancy and lactation.
|
|
Adverse Reactions
Significant: Corneal damage, keratitis and tolerance (w/ prolonged use).
GI: Occasional nausea, vomiting, dysphagia. Ophthalmologic: Transient stinging and burning sensation, blurred vision; stromal infiltration, candida/disciform keratitis, oedema, peripheral corneal formation, epithelial corneal damage (frequent use). Immunologic: Allergic reactions (e.g. contact allergy, urticaria, angioneurotic oedema). |
|
Patient Counseling Information
This drug may cause transient blurring of vision, if affected, do not drive or operate machinery. Avoid dust and bacterial contamination of anaesthetised eye.
|
|
Action
Description: Oxybuprocaine, a para-aminobenzoic acid ester, is a local, surface anaesthesia. It reversibly inhibits the conduction of nerve impulses along nerve axons and the excitability of nociceptors thereby reducing pain sensation.
Onset: Approx 1 min. Duration: 20-40 min. Pharmacokinetics: Absorption: Rapidly and readily absorbed into systemic circulation. Metabolism: Metabolised by plasma cholinesterases; to a lesser extent, metabolised in the liver mainly to 3-butoxy-4-aminobenzoic acid and other metabolites. |
|
Chemical Structure
 Source: National Center for Biotechnology Information. PubChem Database. Oxybuprocaine, CID=4633, https://pubchem.ncbi.nlm.nih.gov/compound/Oxybuprocaine (accessed on Jan. 22, 2020) |
|
Storage
Store between 2-8°C. Do not freeze. Protect from light.
|
|
MIMS Class
|
|
ATC Classification
S01HA02 - oxybuprocaine ; Belongs to the class of local ophthalmologic anesthetics.
|
|
References
Buckingham R (ed). Oxybuprocaine Hydrochloride. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 12/09/2017. Joint Formulary Committee. Oxybuprocaine Hydrochloride. British National Formulary [online]. London. BMJ Group and Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 12/09/2017.
|
Sign Out
